Screener
Omnicell OMCL Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $322.75M-25.2% | $290.97M-29.8% | $251.03M-37.0% | $225.46M-62.0% | $431.5M-25.4% | ||
| $96.72M-8.6% | $99.2M+8.8% | $100.91M+13.8% | $107.43M+13.0% | $105.78M+13.4% | ||
| $735.39M-12.9% | $722.3M-14.0% | $680.07M-16.6% | $659.62M-34.8% | $844.78M-15.2% | ||
| $121.95M+2.5% | $121.5M+4.9% | $120.11M+6.6% | $119.61M+7.0% | $118.95M+7.2% | ||
| $737.2M-0.2% | $737.29M+0.2% | $737.95M+0.4% | $737.87M+0.1% | $738.49M+0.4% | ||
| $160.86M-9.3% | $165.43M-9.4% | $170.11M-9.6% | $172.04M-11.3% | $177.35M-11.1% | ||
| $2B-6.8% | $2B-6.8% | $1.97B-6.9% | $1.95B-15.4% | $2.15B-6.4% | ||
| $49.78M-20.2% | $58.34M+9.5% | $43.99M-15.0% | $62.49M+30.7% | $62.41M+25.5% | ||
| $188.37M+22.6% | $211.89M+32.4% | $171.86M+21.6% | $178.78M+17.3% | $153.6M+2.2% | ||
| $447.44M-24.7% | $483.05M-20.5% | $476.61M-20.0% | $456.59M-52.5% | $594.39M+46.0% | ||
| $707.25M-19.8% | $747.48M-16.4% | $742.91M-15.4% | $727.7M-32.1% | $881.88M-19.0% | ||
| 100M0.0% | 100M0.0% | 100M+175,339% | 100M0.0% | 100M0.0% | ||
| $420.59M+10.2% | $396.3M+5.4% | $384.94M+0.5% | $386.97M+5.4% | $381.5M+6.4% | ||
| $1.29B+2.2% | $1.26B0.0% | $1.23B-0.9% | $1.22B-0.8% | $1.26B+5.1% | ||
| $2B-6.8% | $2B-6.8% | $1.97B-6.9% | $1.95B-15.4% | $2.15B-6.4% |
FAQ
- What are Omnicell's total assets?
- Omnicell (OMCL) holds $2.0B in total assets, down 6.8% year over year.
- How much debt does Omnicell have?
- Omnicell carries $31.8M in total debt against $1.3B of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Omnicell have?
- Omnicell holds $322.8M in cash and equivalents.
- Can Omnicell cover its short-term obligations?
- Its current ratio is 1.64 — current assets exceed current liabilities.
- Where does Omnicell's balance sheet data come from?
- Every line is extracted from Omnicell's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
